MRD in AML: time for redefinition of CR?

Blood. 2013 Mar 21;121(12):2166-8. doi: 10.1182/blood-2013-01-480590.
No abstract available

Publication types

  • Comment

MeSH terms

  • Core Binding Factors / genetics*
  • Female
  • Genes, Neoplasm*
  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Leukemia, Myeloid, Acute / pathology*
  • Male
  • Mutation*

Substances

  • Core Binding Factors